<DOC>
	<DOC>NCT02260141</DOC>
	<brief_summary>To study the effectiveness of d-ribose in treating Alzheimer's and Dementia</brief_summary>
	<brief_title>Treating Alzheimer's and Dementia With D-ribose</brief_title>
	<detailed_description>Clinical experience and the pathophysiology of Alzheimer's, including neuronal insulin resistance, suggests that ribose improves clinical outcomes. This study will add ribose 5 gm 3 X day for 8 weeks to monitor outcomes in a pilot study.</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<criteria>A diagnosis of Alzheimer's and/or dementia with a Mini Mental Status Exam ( MMSE) score over 12 or being ambulatory and able to travel outside the home with assistance. Must have a caregiver living with them. Overt and severe causes of secondary dementia such as metastatic brain cancers, or severe overt infectious encephalopathies or severe autoimmune illness. Also, severe life threatening illnesses which would make them unlikely to be alive after 612 months.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>